... Epeius Biotechnologies,Corporation today announced that Rexin-G has ... and Drug Administration (FDA) for the,treatment of all ... third,clinical indication for which Rexin-G has been formally ... latest approval for Rexin-G validates the,company,s remarkable strategy ...
... 8, 2008Biotech and pharmaceutical firms are developing a ... complicated drug discovery process, reports Genetic Engineering ... successful approaches rely on a combination of high-throughput ... according to an article in the July issue ...
... in nanoscale lithographic technology, used in the manufacture of ... patterns of lines over larger areas than have been ... could pave the way for next-generation computer memory and ... other devices. , The team has created lines about ...
Other Biology Technology:FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas 2FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas 3MIT reports finer lines for microchips 2... Mouse monoclonal [YPF19] to Yersinia ... to detect Yersinia pestis . ... from Yersinia pestis vaccine ... This antibody recognises Y.pestis F1 capsular ...
Rabbit polyclonal to ZFP200 ( Abpromise for all tested applications). Antigen: Synthetic peptide: CGKSFNHKTNLNKHER (Human) Entrez Gene ID: 7752 Swiss Protein ID: P98182...
Anti-human C3a/C3a des-Arg (neo-epitope), Clone 2991, Monoclonal Antibody...
Rabbit polyclonal to Leucyl tRNA synthetase ( Abpromise for all tested applications). Antigen: L930-H1176 denatured human recombinant LRS. Entrez Gene ID: 3926 Swiss Protein ID: Q9P2J5...
Biology Products: